成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 6106-41-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 6106-41-8
Chemical Structure| 6106-41-8
Structure of 6106-41-8 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 6106-41-8 ]

Related Doc. of [ 6106-41-8 ]

Alternatived Products of [ 6106-41-8 ]
Product Citations

Product Citations      Expand+

Robertson, Hayden ; Willott, Joshua D. ; Gregory, Kasimir P. , et al. DOI: PubMed ID:

Abstract: Hypothesis Specific ion effects govern myriad biological phenomena, including protein–ligand interactions and enzyme activity. Despite recent advances, detailed understanding of the role of ion hydrophobicity in specific ion effects, and the intersection with hydrotropic effects, remains elusive. Short chain fatty acid sodium salts are simple amphiphiles which play an integral role in our gastrointestinal health. We hypothesise that increasing a fatty acid’s hydrophobicity will manifest stronger salting-out behaviour. Experiments Here we study the effect of these amphiphiles on an exemplar thermoresponsive polymer brush system, conserving the carboxylate anion identity while varying anion hydrophobicity via the carbon chain length. Ellipsometry and quartz crystal microbalance with dissipation monitoring were used to characterise the thermoresponse and viscoelasticity of the brush, respectively, whilst neutron reflectometry was used to reveal the internal structure of the brush. Diffusion-ordered nuclear magnetic resonance spectroscopy and computational investigations provide insight into polymer-ion interactions. Findings Surface sensitive techniques unveiled a non-monotonic trend in salting-out ability with increasing anion hydrophobicity, revealing the bundle-like morphology of the ion-collapsed system. An intersection between ion-specific and hydrotropic effects was observed both experimentally and computationally; trending from good anti-hydrotrope towards hydrotropic behaviour with increasing anion hydrophobicity, accompanying a change in hydrophobic hydration.

Keywords: Hofmeister ; Hydrophobic effect ; Hydrotrope ; Polymer brush ; Short-chain fatty acids ; Specific ion effects ; Surface chemistry ; Thin films

Purchased from AmBeed:

Suresh C Bokoliya ; Jordan Russel ; Yair Dorsett , et al. DOI: PubMed ID:

Abstract: Background: Despite serious health and social consequences, effective intervention strategies for habitual alcohol binge drinking are lacking. Development of novel therapeutic and preventative approaches is highly desirable. Accumulating evidence in the past several years has established associations between the gut microbiome and microbial metabolites with drinking behavior, but druggable targets and their underlying mechanism of action are understudied. Results: Here, using a drink-in-the-dark mouse model, we identified a microbiome metabolite-based novel treatment (sodium valerate) that can reduce excessive alcohol drinking. Sodium valerate is a sodium salt of valeric acidshort-chain-fatty-acid with similar structure as γ-aminobutyric acid (GABA). Ten days of oral sodium valerate supplementation attenuates excessive alcohol drinking by 40%, reduces blood ethanol concentration by 53%, and improves anxiety-like or approach-avoidance behavior in male mice, without affecting overall food and water intake. Mechanistically, sodium valerate supplementation increases GABA levels across stool, blood, and amygdala. It also significantly increases H4 acetylation in the amygdala of mice. Transcriptomics analysis of the amygdala revealed that sodium valerate supplementation led to changes in gene expression associated with functional pathways including potassium voltage-gated channels, inflammation, glutamate degradation, L-DOPA degradation, and psychological behaviors. 16S microbiome profiling showed that sodium valerate supplementation shifts the gut microbiome composition and decreases microbiome-derived neuroactive compounds through GABA degradation in the gut microbiome. Conclusion: Our findings suggest that the sodium valerate holds promise as an innovative therapeutic avenue for the reduction of habitual binge drinking, potentially through multifaceted mechanisms.

Keywords: Alcohol drinking ; SCFA ; Sodium valerate ; GABA ; Microbiome

Purchased from AmBeed:

Krimitza, Elisavet ;

Abstract: Gut microbiota –the assembly of commensal intestinal microorganisms - impacts the host immune system in several ways. Antibiotics -widely used therapeutic agents- are able to modulate the survival and the growth of gut bacteria, as well as the metabolites they produce. Some gut bacteria are already known to affect the T cell development and differentiation. This research thesis investigates the impact that certain antibiotics and metabolites (short chain fatty acids) could have on antigen presentation and T cell activation. Through series of assays evaluating the antigen presentation to CD8+ T cells, this thesis has shown that different metabolites have distinct effects, some are able to boost and others to inhibit the immune responses. We suggest that different metabolites may act through distinct signaling and cytokine transduction pathways. Factors like the concentrations, the timing and the duration of exposure of the APCs to those treatments, together with the type of the metabolite, might hold a role in the activation of different pathways as well. Among the metabolites we tested, propionate was shown to have inhibitory effects on antigen presentation, and the mechanism behind this is probably related to the antigen processing, through upregulation of the IFNα gene. Butyrate might be regulating the expression of the MHC II gene. Antibiotics were found to have no direct impact on T cell activation in vitro or in vivo. Even though the complexity of the gut microbiota impact on the immune system still needs further studies, we overall suggest that fine regulation of the gut metabolites can largely affect the clinical outcomes of multiple therapies.

Keywords: gut microbiome ; immune system ; metabolites ; antigen presentation ; T cell activation

Purchased from AmBeed:

Product Details of [ 6106-41-8 ]

CAS No. :6106-41-8 MDL No. :MFCD00066205
Formula : C5H9NaO2 Boiling Point : -
Linear Structure Formula :- InChI Key :LHYPLJGBYPAQAK-UHFFFAOYSA-M
M.W : 124.11 Pubchem ID :3669864
Synonyms :

Calculated chemistry of [ 6106-41-8 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.8
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 25.98
TPSA : 40.13 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.07 cm/s

Lipophilicity

Log Po/w (iLOGP) : -11.96
Log Po/w (XLOGP3) : 1.39
Log Po/w (WLOGP) : -0.07
Log Po/w (MLOGP) : 0.89
Log Po/w (SILICOS-IT) : 0.52
Consensus Log Po/w : -1.84

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.29
Solubility : 6.41 mg/ml ; 0.0516 mol/l
Class : Very soluble
Log S (Ali) : -1.84
Solubility : 1.81 mg/ml ; 0.0146 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.78
Solubility : 20.6 mg/ml ; 0.166 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 6106-41-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 6106-41-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 6106-41-8 ]

[ 6106-41-8 ] Synthesis Path-Downstream   1~21

  • 1
  • [ 79-37-8 ]
  • [ 6106-41-8 ]
  • [ 71-43-2 ]
  • [ 2082-59-9 ]
  • 2
  • [ 39074-38-9 ]
  • [ 6106-41-8 ]
  • [ 50887-98-4 ]
  • 3
  • [ 39074-64-1 ]
  • [ 6106-41-8 ]
  • [ 40151-69-7 ]
  • 4
  • [ 39073-67-1 ]
  • [ 6106-41-8 ]
  • [ 50888-06-7 ]
  • 5
  • [ 6106-41-8 ]
  • Chloromethyl-(3-chloro-phenyl)-carbamic acid sec-butyl ester [ No CAS ]
  • Pentanoic acid [sec-butoxycarbonyl-(3-chloro-phenyl)-amino]-methyl ester [ No CAS ]
  • 6
  • [ 6106-41-8 ]
  • [ 133217-42-2 ]
  • [ 133217-58-0 ]
  • 7
  • [ 6106-41-8 ]
  • C40H48N2O10 [ No CAS ]
  • [ 103068-46-8 ]
  • 8
  • [ 6106-41-8 ]
  • [ 103068-46-8 ]
  • [ 103068-50-4 ]
  • 12
  • [ 67-56-1 ]
  • [ 6106-41-8 ]
  • daunorubicin hydrochloride [ No CAS ]
  • Pentanoic acid 2-[(2S,4S)-4-((1R,3S,4R,5R)-3-amino-4-hydroxy-5-methyl-cyclohexyloxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-naphthacen-2-yl]-2,2-dimethoxy-ethyl ester [ No CAS ]
  • 13
  • [ 2082-59-9 ]
  • [ 3759-28-2 ]
  • [ 6106-41-8 ]
  • [ 436801-28-4 ]
  • 14
  • [ 2082-59-9 ]
  • [ 28970-92-5 ]
  • [ 6106-41-8 ]
  • [ 436801-29-5 ]
  • 15
  • [ 2082-59-9 ]
  • [ 6106-41-8 ]
  • [ 436801-25-1 ]
  • [ 436801-30-8 ]
  • 16
  • [ 52-67-5 ]
  • [ 2082-59-9 ]
  • [ 6106-41-8 ]
  • N-valeryl-D-penicillamine [ No CAS ]
  • 17
  • [ 6106-41-8 ]
  • [ 85416-19-9 ]
  • 9-valeryloxyacetyl-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydronaphthacene-5,12-dione [ No CAS ]
YieldReaction ConditionsOperation in experiment
In acetone; (1) A mixture of 9-bromoacetyl-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydronaphthacene-5,12-dione (1.00 g) obtained in Reference Example 1-(1), <strong>[6106-41-8]sodium valerate</strong> (1.44 g) and acetone (50 ml) was stirred under reflux for 5 hours, cooled to room temperature and concentrated under reduced pressure. The residue was triturated with an adequate quantity of ether, and solid substances were filtered to give reddish crystals of 9-valeryloxyacetyl-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydronaphthacene-5,12-dione. M.P., 170°-172° C. IR (Nujol) nucm-1: 3400, 1775, 1770, 1620, 1585. NMR (CDCl3) delta: 0.83-3.15 (m, 16H), 5.12 (bs, 2H), 7.80 (m, 2H), 8.30 (m, 2H), 13.37 (bs, 2H).
In acetone; (1) A mixture of 9(R)-bromoacetyl-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydronaphthacene-5,12-dione (1.00 g) obtained in Reference Example 4-(1), <strong>[6106-41-8]sodium valerate</strong> (1.44 g) and acetone (50 ml) was stirred under reflux for 2 hours. After removing insoluble matters by filtration, the reaction mixture was concentrated under reduced pressure. The residue was treated with ether (15 ml) and precipitated crystals were collected by filtration to give orange crystals of 9(R)-valeryloxyacetyl-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydronaphthacene-5,12-dione. M.P., 149°-152° C. IR (Nujol) nucm-1: 1730, 1620, 1585. NMR (CDCl3) delta: 1.93 (t, J=6 Hz, 3H), 1.16-2.30 (m, 6H), 2.32-2.63 (m, 2H), 2.93 (bs, 4H), 5.20 (s, 2H), 7.60-7.87 (m, 2H), 8.00-8.26 (m, 2H).
  • 19
  • uranyl(VI) nitrate [ No CAS ]
  • [ 7722-84-1 ]
  • [ 6106-41-8 ]
  • 2UO2(2+)*2Na(1+)*4C4H9CO2(1-)*O2(2-)*13H2O=2NaC4H9CO2*UO2(C4H9CO2)2*UO4*13H2O [ No CAS ]
  • 21
  • {Pd(C10H21OC6H3CH=NN=CHC6H4OC10H21)(μ-Cl)}2 [ No CAS ]
  • [ 6106-41-8 ]
  • [ 127421-26-5 ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Similar Product of
[ 6106-41-8 ]

Chemical Structure| N/A

A1369490[ N/A ]

Sodium pentanoate-1-13C

Reason: Stable Isotope

Related Functional Groups of
[ 6106-41-8 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 37435-69-1

[ 37435-69-1 ]

Sodium 5-hydroxypentanoate

Similarity: 1.00

Chemical Structure| 111-16-0

[ 111-16-0 ]

Heptanedioic acid

Similarity: 0.94

Chemical Structure| 505-95-3

[ 505-95-3 ]

12-Hydroxydodecanoic acid

Similarity: 0.94

Chemical Structure| 1679-53-4

[ 1679-53-4 ]

10-Hydroxydecanoic acid

Similarity: 0.94

Chemical Structure| 143-07-7

[ 143-07-7 ]

Dodecanoic Acid

Similarity: 0.94

Carboxylic Acid Salts

Chemical Structure| 37435-69-1

[ 37435-69-1 ]

Sodium 5-hydroxypentanoate

Similarity: 1.00

Chemical Structure| 822-16-2

[ 822-16-2 ]

Sodium stearate

Similarity: 1.00

Chemical Structure| 21810-34-4

[ 21810-34-4 ]

Potassium 6-hydroxyhexanoate

Similarity: 0.89

Chemical Structure| 17378-36-8

[ 17378-36-8 ]

Potassium heptadecanoate

Similarity: 0.89

Chemical Structure| 19402-63-2

[ 19402-63-2 ]

Ammonium decanedioate

Similarity: 0.89

; ;